Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Mark A Socinski

Abstract

A 1995 meta-analysis of nine trials involving 1190 patients by the Non-Small Cell Lung Cancer Collaborative Group reported that in advanced metastatic disease, platinum-based chemotherapy provides a survival benefit compared with best supportive care. Since then, several randomized trials using either platinum-based combination regimens or selected new single agents have confirmed this observation of a modest survival advantage, as well as improved quality of life. New agents such as paclitaxel, docetaxel, vinorelbine, gemcitabine, and irinotecan have shown significant single-agent activity in advanced non-small cell lung cancer. Two recent meta-analyses have suggested that regimens including these newer agents offer modest improvement in outcomes compared with older regimens. Several randomized trials have evaluated these modern platinum-based doublets and suggested that no one combination is superior when using survival as the primary measure of outcome. Future research may improve outcomes through identifying prognostic markers of treatment response to both standard cytotoxic and newer "targeted" therapies.

References

Jul 14, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S ThongprasertJ Clinch
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H CullenR L Souhami
Mar 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Extermann
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A ShepherdJ Berille
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I E SmithS Ashley
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O S BreathnachB E Johnson
May 30, 2001·Lancet·V GeorgouliasUNKNOWN Greek Oncology Cooperative Group (GOCG) for Lung Cancer
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paris KosmidisMeletios Dimopoulos
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V ScagliottiUNKNOWN Italian Lung Cancer Project
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angela GradiloneAnna Maria Aglianò
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V AlberolaUNKNOWN Spanish Lung Cancer Group

❮ Previous
Next ❯

Citations

Nov 18, 2006·BMJ : British Medical Journal·Matthew Links
May 2, 2014·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Cesar Augusto Sam Tiago Vilanova-CostaElisângela de Paula Silveira-Lacerda
Dec 7, 2011·Biological Trace Element Research·Aliny Pereira de LimaElisângela de Paula Silveira-Lacerda
Nov 3, 2009·Expert Opinion on Investigational Drugs·Eitan AmirBalazs Dome
Dec 15, 2010·Expert Opinion on Investigational Drugs·Paul A NguewaRajkumar Savai
Aug 26, 2014·Experimental Lung Research·Shenxu WangFeng Cao
Jan 25, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chun-Ming TsaiKuo-Ting Chang
Sep 27, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Francesco ZappaUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Jul 4, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·R MouleR Eeles
Dec 17, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Katharina LeithnerHorst Olschewski
Jul 9, 2008·Critical Reviews in Oncology/hematology·Marianna AitaFrancesco Grossi
Feb 5, 2008·Critical Reviews in Oncology/hematology·Francesco GrossiFilippo De Marinis
Nov 18, 2005·Clinical Therapeutics·Kristan D Rollins, Celeste Lindley
Dec 6, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yin TianZheng Li
Jun 2, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hitoshi KawazoeHitoshi Houchi
Jun 8, 2007·Expert Review of Proteomics·L Alex Gaither
Jan 1, 2010·Oncology Letters·Anna OfverholmCharlotta Enerbäck
Aug 2, 2020·Expert Opinion on Pharmacotherapy·Jiyun LeeMyung-Ju Ahn
Jun 15, 2017·Clinical Pharmacokinetics·Tore B StageDeanna L Kroetz
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anna BerkenblitJeffrey G Supko
Nov 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anja HenningssonHoward L McLeod
Dec 31, 2020·Pharmacogenomics and Personalized Medicine·Xiaohua LiYifeng Bai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.